Global Pharmaceuticals & Biotech Most Popular Stocks

Gufic Biosciences

Market Cap: ₹35.8b

Manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally.

Humedix

Market Cap: ₩566.6b

Engages in the manufacture and sale of various pharmaceutical products in South Korea.

ETHZilla

Market Cap: US$402.0m

Operates as a technology company in the decentralized finance industry.

I-Mab

Market Cap: US$400.6m

A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.

Gongwin Biopharm Holdings

Market Cap: NT$12.2b

A clinical-stage biopharmaceutical company, develops anticancer drugs.

Cuorips

Market Cap: JP¥59.6b

Engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets.

Shandong Sito Bio-technology

Market Cap: CN¥2.8b

Researches, develops, and produces steroid biomedicine intermediates.

Qinghai Spring Medicinal Resources Technology

Market Cap: CN¥2.8b

Qinghai Spring Medicinal Resources Technology Co., Ltd.

4D Molecular Therapeutics

Market Cap: US$391.8m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Cutia Therapeutics

Market Cap: HK$3.0b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

Lineage Cell Therapeutics

Market Cap: US$390.5m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

Tus-Pharmaceutical Group

Market Cap: CN¥2.8b

Manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China.

Evolus

Market Cap: US$387.5m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

ALT5 Sigma

Market Cap: US$387.3m

Provides blockchain-powered technologies worldwide.

Northwest Biotherapeutics

Market Cap: US$387.2m

A biotechnology company, focuses on developing personalized immune therapies for cancer.

Anhui Wanbang Pharmaceutical TechnologyLtd

Market Cap: CN¥2.8b

Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

Kamada

Market Cap: ₪1.3b

Manufactures and sells plasma-derived protein therapeutics.

Assembly Biosciences

Market Cap: US$383.9m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

Aura Biosciences

Market Cap: US$382.7m

A clinical-stage biotechnology company, develops precision therapies to treat solid tumors.

Antibiotice

Market Cap: RON 1.7b

Produces and sells medicinal products in Romania and internationally.

Korro Bio

Market Cap: US$381.8m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.

Mabpharm

Market Cap: HK$3.0b

A biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People’s Republic of China.

IntoCell

Market Cap: ₩537.5b

Develops protein-drug conjugates for the treatment of cancer.

Huons Global

Market Cap: ₩537.1b

Manufactures and sells pharmaceutical products for human health in South Korea and internationally.

Bright Minds Biosciences

Market Cap: CA$530.9m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Hanshang Group

Market Cap: CN¥2.7b

Primarily engages in the retail business.

Unichem Laboratories

Market Cap: ₹33.7b

A pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally.

BINEX

Market Cap: ₩535.0b

Operates as a pharmaceutical company in South Korea.

PYC Therapeutics

Market Cap: AU$577.4m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Jacobson Pharma

Market Cap: HK$2.9b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

Essex Bio-Technology

Market Cap: HK$2.9b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

Genomictree

Market Cap: ₩529.6b

A biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases.

Design Therapeutics

Market Cap: US$374.1m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Clinuvel Pharmaceuticals

Market Cap: AU$566.4m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Annexon

Market Cap: US$370.3m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

Jilin Jian Yisheng Pharmaceutical

Market Cap: CN¥2.6b

Engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China.